NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.84−0.07 (-3.91%)
Close on Nov 20, 2026Market cap $146.95MP/E –Yield –
NervGen Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 72M, up 7.4% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 72M | +7.4% |
| FY2024 | Dec 31, 2024 | 67M | – |
See a number that looks wrong?